Grupo Supervielle S.A.
NYSE:SUPVBanks - Regional
+$0.39 today
- Market cap
- $501.84M
- Beta
- 0.42
- P/E (TTM)
- -27.8
- EPS (TTM)
- -$125.34
Volume 0.94M
Average 0.80M
SUPV Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Grupo Supervielle S.A.NYSE: SUPV
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was ARS 0, compared with ARS 0 a year earlier. Trailing-twelve-month research & development was ARS 0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near ARS 0 or moves back toward the trailing-twelve-month quarterly average of ARS 0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
ARS · from the income statement
- Latest · FY2025
- 0 ARS
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How SUPV compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for SUPV, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | ARS 0 ARS | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding SUPV) | — | — | — | 0.0% | |
Competitors are the stored peer set for SUPV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 793.88B | 1.96T | 3.02T | 2.04T | 2.33T |
| Cost of Revenue | 412.4B | 1.1T | 1.79T | 885.33B | 1.41T |
| Gross Profit | 381.48B | 859.83B | 1.23T | 1.16T | 918.05B |
| Gross Margin | 48.1% | 43.8% | 40.8% | 56.7% | 39.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 209.1B | 476.91B | 449.73B | 405.27B | 381.27B |
| Operating Expenses | 390.32B | 918.27B | 1.04T | 1.02T | 1.03T |
| Depreciation & Amortization | 25.63B | 68.48B | 69.53B | 52.26B | 0 |
| EBITDA | 16.79B | 10.04B | 257.67B | 195.12B | (112.72B) |
| EBITDA Margin | 2.1% | 0.5% | 8.5% | 9.5% | -4.8% |
| Operating Income | (8.83B) | (58.44B) | 188.13B | 142.87B | (112.72B) |
| Operating Margin | -1.1% | -3.0% | 6.2% | 7.0% | -4.8% |
| Interest Income | 629.19B | 1.71T | 2.53T | 1.66T | 2.04T |
| Interest Expense | 368.62B | 1.13T | 1.8T | 889.93B | 1.1T |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | (8.83B) | (58.44B) | 188.13B | 142.87B | (112.72B) |
| Pre-Tax Margin | -1.1% | -3.0% | 6.2% | 7.0% | -4.8% |
| Income Tax Expense | 1.7B | (24.31B) | 75.64B | 38.3B | (55.99B) |
| Net Income | (10.52B) | (34.09B) | 112.4B | 104.49B | (56.6B) |
| Net Margin | -1.3% | -1.7% | 3.7% | 5.1% | -2.4% |
| EPS (Basic) | (9.40) | (172.30) | 582.95 | 1,423.60 | (652.95) |
| EPS (Diluted) | (9.40) | (172.30) | 582.95 | 1,423.60 | (652.95) |
| Weighted Avg Shares | 91.34M | 88.53M | 88.55M | 87.93M | 87.54M |
| Weighted Avg Shares (Diluted) | 91.34M | 90.85M | 88.55M | 87.93M | 87.54M |
Grupo Supervielle S.A.
NYSE:SUPV
Intrinsic Alpha fair value
Locked
Current Price
$5.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.